Impulse Dynamics

Impulse Dynamics announced the first implantation of the Optimizer IVs device in Poland

Impulse Dynamics
August 13, 2015


Impulse Dynamics announced the first implantation of the Optimizer IVs device in Poland

Stuttgart, Germany – August 13th, 2015 – Impulse Dynamics announced today (13 August, 2015) the first implantation of its Optimizer IVs device in Poland, at the University Hospital  – Central Veterans’ Hospital in Lodz.  The implantation was performed by Dr. Krzysztof Kaczmarek and Professor Paweł Ptaszyński.  The Department of Electrocardiology in Lodz managed by Professor Jerzy K Wranicz is one of the leading EP Centers in Poland performing most interventional treatment options in patients with arrhythmias.

The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF).  The device is based on novel Cardiac Contractility Modulation (CCM) technology, and delivers non-excitatory electric pulses to the heart.

“We are very pleased to provide the Optimizer system to our patients who can now benefit from the CCM therapy that is well established in many other countries.  This therapy addresses a major unmet clinical need for patients with a narrow QRS complex that are not adequately controlled with pharmaceutical treatment alone, and currently have no other device-based options” commented Professor Ptaszynski.  “We would like to thank the Univ. Hospital Mannheim and its Cardiology Department, led by Prof. Martin Borggrefe, for the great support”.

“We are very pleased to be able to add Poland to the list of countries that offer the CCM therapy, delivered by the Optimizer device, to its patients” said Dr. Simos Kedikoglou, CEO of Impulse Dynamics.  “CCM is a technology that meets a major need globally, and we are committed to expanding its introduction through healthcare systems worldwide to benefit more patients with heart failure.“

About the Optimizer and CCM Therapy
CCM is the brand name for Cardiac Contractility Modulation, the non-excitatory electrical pulses delivered by the implantable Optimizer device during the absolute refractory period of the heart’s cardiac cycle to improve systolic contraction of the heart. The Optimizer System has been implanted in over 4,000 patients and is currently available in the US, Europe, China, Brazil, India, and more than 40 other countries around the world. Impulse Dynamics has completed numerous clinical studies, including several randomized controlled trials, and the results have been published in over 80 articles appearing in leading medical journals.


About Impulse Dynamics
Impulse Dynamics is a medical device company dedicated to transforming the treatment of chronic heart failure. With global headquarters in Mount Laurel, N.J., the company has additional offices in; Stuttgart, Germany, Orangeburg, N.Y. and Curacao For more information please visit

Impulse Dynamics (USA), Inc.
523 Fellowship Road, Suite 203
Mt. Laurel, NJ 08054